Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors

被引：0
|
作者：
Kuma, A. Benneh-Akwasi [1 ,2 ]
Amponsah, E. [3 ]
Kyeremeh, R. [3 ]
Olayemi, E. [1 ,2 ]
机构：
[1] Univ Ghana, Haematol, Accra, Ghana
[2] Korle Bu Teaching Hosp, Accra, Ghana
[3] Univ Ghana, Med Lab Sci, Accra, Ghana
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
Chronic myeloid leukaemia; Ghana; Quality of Life; Tyrosine Kinase Inhibitor;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Adherence assessment in Chronic Myeloid Leukaemia patients treated by tyrosine kinase inhibitors
    Daouphars, M.
    Ouvry, M.
    Lenain, P.
    Rouvet, J.
    Varin, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 414 - 415
  • [2] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Anna Rychter
    Piotr Jerzmanowski
    Adam Hołub
    Zofia Specht-Szwoch
    Violetta Kalinowska
    Urszula Tęgowska
    Ilona Seferyńska
    Agnieszka Kołkowska-Leśniak
    Ewa Lech-Marańda
    Joanna Góra-Tybor
    Medical Oncology, 2017, 34
  • [3] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
    Rychter, Anna
    Jerzmanowski, Piotr
    Holub, Adam
    Specht-Szwoch, Zofia
    Kalinowska, Violetta
    Tegowska, Urszula
    Seferynska, Ilona
    Kolkowska-Lesniak, Agnieszka
    Lech-Maranda, Ewa
    Gora-Tybor, Joanna
    MEDICAL ONCOLOGY, 2017, 34 (06)
  • [4] Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors
    Piekarska, Agnieszka
    Gil, Lidia
    Jakitowicz, Karolina
    Prejzner, Witold
    Komarnicki, Mieczyslaw
    Hellmann, Andrzej
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 414 - 417
  • [5] The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors
    Efficace, Fabio
    Cannella, Laura
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 170 - 179
  • [6] Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
    Allegra, Sarah
    Dondi, Emma
    Chiara, Francesco
    De Francia, Silvia
    BIOMEDICINES, 2023, 11 (09)
  • [7] Adverse outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors - Reply
    Leong, Darryl
    Hillis, Christopher
    Aghel, Nazanin
    Pond, Gregory
    Seow, Hsien
    HEART, 2021, 107 (20) : 1680 - 1681
  • [8] Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Casavecchia, Grazia
    Spinosa, Giuseppina
    De Gennaro, Luisa
    Zicchino, Stefano
    Gravina, Matteo
    Magnesa, Michele
    Di Biase, Matteo
    Brunetti, Natale Daniele
    ACTA CARDIOLOGICA, 2022, 77 (02) : 130 - 135
  • [9] Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors
    Coetzee, Marius J.
    Louw, Vernon J.
    Gartrell, Kevin
    Viljoen, Chris D.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2009, 99 (12): : 870 - 871
  • [10] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Gianantonio Rosti
    Fausto Castagnetti
    Gabriele Gugliotta
    Michele Baccarani
    Nature Reviews Clinical Oncology, 2017, 14 : 141 - 154
12345